ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,000 | -2.3% | 28,716 | -5.3% | 0.00% | 0.0% |
| Q2 2023 | $603,000 | -76.2% | 30,329 | -79.5% | 0.00% | -83.3% |
| Q1 2023 | $2,531,000 | +39.9% | 147,729 | +59.6% | 0.01% | +50.0% |
| Q4 2022 | $1,809,000 | +312.1% | 92,554 | +237.2% | 0.00% | +300.0% |
| Q3 2022 | $439,000 | +5.5% | 27,447 | -8.8% | 0.00% | 0.0% |
| Q2 2022 | $416,000 | +23.8% | 30,100 | +43.3% | 0.00% | 0.0% |
| Q1 2022 | $336,000 | -4.3% | 21,000 | +30.3% | 0.00% | 0.0% |
| Q4 2021 | $351,000 | -23.7% | 16,121 | +5.0% | 0.00% | 0.0% |
| Q3 2021 | $460,000 | -35.8% | 15,360 | -5.0% | 0.00% | -50.0% |
| Q2 2021 | $716,000 | -4.5% | 16,160 | -4.7% | 0.00% | 0.0% |
| Q1 2021 | $750,000 | -25.1% | 16,950 | -7.0% | 0.00% | -50.0% |
| Q4 2020 | $1,001,000 | +93.2% | 18,233 | -19.7% | 0.00% | +33.3% |
| Q3 2020 | $518,000 | +13.1% | 22,700 | +3.7% | 0.00% | +50.0% |
| Q2 2020 | $458,000 | +28.7% | 21,900 | -13.9% | 0.00% | 0.0% |
| Q1 2020 | $356,000 | -35.5% | 25,450 | +5.2% | 0.00% | -33.3% |
| Q4 2019 | $552,000 | +265.6% | 24,200 | +142.0% | 0.00% | +200.0% |
| Q2 2019 | $151,000 | -14.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $176,000 | -58.3% | 10,000 | -53.1% | 0.00% | -66.7% |
| Q2 2018 | $422,000 | – | 21,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |